You are now leaving the Gen-Probe US site and entering our Global site which contains information on products which are non FDA-Approved and not available for purchase in the US.

Do you wish to continue to this product-specific site?

Gen-Probe
  • Home
  • |
  • Contact Us
  • |
  • Visit Global Site
  • About Us
  • Investors
  • News
  • Products & Services
  • Pipeline
  • Science
  • Careers
  • Package Inserts
  • Home
  • ›
  • News
    News
  • Press Releases
  • Financial Press Releases
  • Press Release Archive
  • Industry Events
  • Product Catalog
  • Package Inserts
  • Customer Service

Press Releases

Date Title
05/08/12 Printer Friendly Version FDA Clears Gen-Probe's PANTHER® System for use with APTIMA Combo 2® Assay
05/03/12 Printer Friendly Version Gen-Probe Withdraws from Previously Announced Investor Presentations
04/30/12 Printer Friendly Version HOLOGIC TO ACQUIRE GEN-PROBE
04/30/12 Printer Friendly Version Gen-Probe Reports Financial Results for the First Quarter of 2012
04/26/12 Printer Friendly Version Gen-Probe to Webcast Three Upcoming Investor Presentations
04/13/12 Printer Friendly Version Gen-Probe Announces Webcast of First Quarter 2012 Earnings Conference Call
03/12/12 Printer Friendly Version Gen-Probe Announces Key Executive Promotions and Additions
02/22/12 Printer Friendly Version Gen-Probe to Webcast Four Upcoming Investor Presentations
02/15/12 Printer Friendly Version FDA Approves Gen-Probe's PROGENSA® PCA3 Assay, First Urine-Based Molecular Test to Help Determine Need for Repeat Prostate Biopsies
02/13/12 Printer Friendly Version Gen-Probe Reports Financial Results for the Fourth Quarter of 2011

TERMS|PRIVACY|HELP|TRADEMARKS|SUPPLY CHAIN TRANSPARENCY
© 1996 - 2012 Gen-Probe Incorporated. All rights reserved.

We want to hear from you! Please send your questions and comments to webmaster@gen-probe.com.

Gen-Probe Incorporated, 10210 Genetic Center Drive, San Diego, CA 92121, USA